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Abstract 
Preterm birth, defined as birth occurring prior to 37 weeks gestation is a common obstetric complication 
affecting 8% of pregnancies and is associated with significant morbidity and mortality.  
Infection/inflammation has been implicated in both the aetiology of preterm birth itself and associated 
neonatal pulmonary and neurological morbidity.  Treatment options are currently limited to prolongation of 
the pregnancy using cervical cerclage, pessaries or progesterone or administration of drugs including steroids 
to promote lung maturity and neuroprotective agents such as magnesium sulphate, the timing of which are 
highly critical.  Although delivery is expedited in cases of overt infection, decisions regarding timing and 
mode of delivery in subclinical infection are not clear-cut.  This review aims to explore the use of Magnetic 
Resonance Imaging (MRI) in the antenatal assessment of pregnancies at high risk of preterm birth and its 
potential to guide management decisions in the future. 
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Background 
Preterm birth (PTB), defined as birth less than 37+0 weeks gestation, is a significant health issue, projected to 
cost health services in England and Wales £939 million per year[1].  Morbidity is inversely correlated to 
gestational age, with the most severe adverse outcomes associated with very PTB, defined as occurring less 
than 32+0 weeks gestation.  These births account for 1.4% of all deliveries in the United Kingdom[2], affecting 
13500 individuals every year.  Of children that are born very preterm, neurodevelopmental sequelae are 
responsible for a significant proportion of the associated morbidity. Up to 10% of surviving infants will 
develop motor impairments in the form of cerebral palsy (CP)[3] and 25-50% will suffer cognitive, 
behavioural, attention and socialisation deficits.  In addition PTB is associated with significant pulmonary 
morbidity including respiratory distress syndrome and bronchopulmonary dysplasia.  
 
Treatments are currently limited to mechanisms aimed at prolongation of the pregnancy, encompassing 
cervical cerclage, pessaries and supplemental progesterone, promoting lung maturity by the appropriate timing 
of administration of antenatal steroids and administration of the neuroprotective agent magnesium sulphate in 
labour.  However, despite these treatments and although survival rates have improved over the last decade for 
extremely preterm infants born between 22 and 26 weeks, rates of disability are unchanged[4]. 
 
The intrauterine environment may contribute to and compound the associated neonatal morbidity.  Infection 
has been implicated in both the aetiology of spontaneous PTB and subsequent cerebral and pulmonary 
pathology. When overt chorioamnionitis is present, prolongation of the pregnancy is detrimental and 
associated with an increased risk of cerebral palsy[5] and iatrogenic delivery is in the best interest of both the 
mother and the child.  However, subclinical infection is known to be common, particularly at lower gestations 
but methods of assessing this are limited.  Decisions regarding the timing of delivery are therefore not clear 
cut, the risks of prematurity being weighed against the likelihood and significance of infection in the fetal 
compartment.  
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The ability to accurately assess fetal development and pathology and the consequences of in utero infection 
as well as to accurately time when spontaneous PTB is likely to occur may significantly improve subsequent 
neonatal morbidity.   This review will explore how antenatal Magnetic Resonance Imaging (MRI) may add to 
the clinical picture in pregnancies at high risk of PTB and help guide management decisions. 
 
MRI 
MRI is a non-invasive imaging technique which has been increasingly utilised for assessing the fetus over the 
last 20 years, partly due to its excellent safety profile[6-8], good soft tissue contrast and anatomical 
delineation, and its ability to provide additional information to obstetric ultrasound[9].  MRI is particularly 
useful in assessing the fetal brain, providing more accurate cerebral biometry, superior visualisation of the 
posterior fossa and assessment of sulcal formation[10, 11].  More recently it has also been used in the 
assessment of non-cerebral fetal structures including the thorax[12] and renal tract[13].  In addition, the 
development of advanced MRI techniques in the fetus including diffusion[14] imaging and spectroscopy[15] 
have facilitated the analysis of tissue microstructure and function of not just fetal tissues but also the maternal 
reproductive tract. 
 
MRI uses a static magnetic field, which aligns the nuclear magnetisation of ions within tissue.  Radiofrequency 
pulses are applied which alter their alignment.  As they return to their original state a radiofrequency signal is 
produced which is detected by a receiver coil placed over the maternal abdomen.  Fourier transformation 
results in the generation of an image.  Image contrast can be weighted in order to optimally assess specific 
structures.  Tissues return to their resting states via a combination of T1 and T2 relaxation: T1 is the time 
required to regain longitudinal magnetization and T2 the transverse relaxation time.  Tissue with a high water 
content such as unmyelinated white matter is seen as low signal intensity (SI) on T1 weighted images and 
high SI on T2 weighted images (see Figure 1). 
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Magnetic resonance spectroscopy (MRS) works on the same principles as MRI but instead of an image, 
Fourier transformation results in the generation of a chemical spectrum.  Metabolites that can be assessed 
using this technique include, N-acetyl aspartate (NAA), Choline (Cho), Creatine (Cr), Myo-inositol (Myo-ins) 
and Lactate[15].  Diffusion weighted imaging is a functional MR technique which provides quantitative 
information about water motion and tissue microstructure[16, 17] apparent diffusion coefficients (ADC) can 
be created to give a quantitative assessment of this process and maps generated. In addition advanced diffusion 
imaging, suitable for tractography and microstructural modelling, can now be obtained from the fetus.  
Although more challenging in the mobile fetus, detailed assessment of the tissue microstructure in vivo by 
measuring diffusion anisotropy (directional dependence) such as occurs within white matter tracts in the brain 
is now possible [18] see Figure 3.  
 
MRI in the second and third trimesters of pregnancy is considered to be a safe imaging modality using both 
1.5T and 3T scanners[19].  Theoretical risks are threefold: from the static magnetic field, the radiofrequency 
field (which causes heating) and from the time-varying magnetic field (resulting in noise). To minimise these 
risks, patients and staff must undergo a comprehensive metal check to ensure they are metal free before 
entering the scanner room, the scanner manufacturer establishes Specific Absorption Rates (SAR) for each 
pulse sequence used[8], the maternal temperature is kept less than 37.5oC, the mother is given ear protection, 
louder sequences are kept to a minimum acquisition time, interspersed with quieter sequences and software 
such as Softtone can also be used to reduce noise.  
 
A full assessment of the fetus, uteroplacental unit and cervix can be obtained in approximately one hour.  
Although performing MRI examinations on women at high risk of PTB can be challenging due to cost 
implications and access to imaging prior to delivery, our research group has demonstrated its feasibility.   
 
Assessment of Fetal Anatomy 
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Although 2D and 3D ultrasound can give extremely detailed pictures of fetal anatomy, views can be restricted 
by fetal position and maternal habitus and the use of a vaginal probe may be undesirable, for example in cases 
of ruptured membranes. MRI can provide additional information to ultrasound including assessment of 
appropriate cortical folding[20], identification of haemorrhage[21], white matter injury and elucidation of 
causes of ventriculomegaly e.g. confirmation of corpus callosal agenesis[21].  The development of advanced 
MR techniques such as diffusion imaging have also enabled the assessment of tissue microstructure and 
identification of lesions not visible on conventional imaging.  An ADC map can be seen in Figure 4. 
 
Detailed information, which may facilitate appropriate counselling and help guide neonatal management plans 
can be obtained from assessment of a number of organs within the fetus. 
 
Brain 
Infection has been implicated in the aetiology of spontaneous PTB and subsequent cerebral pathology.  
Chorioamnionitis is associated with intra-ventricular haemorrhage[22, 23] and pro-inflammatory cytokines, 
including IL-6, TNF alpha and IL-10, within maternal and fetal circulations have been linked to both overt 
and subtle white matter damage[24]. Animal models have indicated infection as the major aetiology for 
neuronal aberrations associated with spontaneous PTB[25].  It is therefore plausible that the process of injury 
to the developing brain actually commences in the antenatal period. 
 
Studies in preterm infants have utilised the early application of MRI as an outcome prediction tool for 
subsequent motor impairment: parenchymal lesions including haemorrhage, periventricular leukomalacia, 
infarction and reduction of white matter are associated with the development of CP[26].  Abnormalities in 
diffusion imaging [27-29] and MRS[30], also predict poor neurodevelopmental outcome. Abnormal cortical 
folding in infants born extremely preterm has also been shown to be associated with poor neurodevelopmental 
outcome at two years, particularly receptive language[31].  However, no studies to date have assessed the 
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brain antenatally in a group of fetuses that deliver very preterm to assess whether these processes begin during 
late pregnancy and whether there is correlation with neonatal MRI findings.  
 
The development of advanced MRI techniques has now enabled assessment of cortical folding[20], subtle 
white matter injury and haemorrhage in the fetus: information not previously obtainable using conventional 
ultrasound imaging techniques.  Volumetry of cerebral structures MRS[32], and diffusion imaging can now 
also be obtained from a fetal MRI. Such information about brain development may be useful with respect to 
counselling of parents with regards to longer-term outcomes as well as helping clinical decision making with 
regards to the timing of delivery or therapeutic interventions. 
 
The timing of delivery may be altered if brain injury is known to have begun antenatally, particularly if this 
is related to an infected intrauterine environment.  Although adverse neurodevelopmental outcomes are 
inversely correlated to gestation[33] the presence of intra-uterine infection is a known antecedent of cerebral 
palsy[34] and in the presence of overt brain injury obstetricians may elect to deliver the fetus earlier in order 
to prevent further injury to the developing brain.  
 
In addition, administration of magnesium sulphate to the mother has been demonstrated to reduce the 
incidence of cerebral palsy[35]. However, questions remain unanswered as to the appropriate dose and timing 
of administration[36].  It is currently given in early labour however, no studies have been performed to assess 
if the process of brain injury has actually begun by this stage. If this is the case, benefit may be conferred by 
its administration prior to the onset of labour. 
 
Further research is therefore needed in order to fully understand the relationship between infection and fetal 
brain development in the antenatal period in women at high risk of PTB.  Correlation of fetal and early neonatal 
MR imaging may also enable prediction of antenatal antecedents of postnatal pathology.  In such cases 
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administration of magnesium sulphate or timely delivery during the antenatal period may prevent the 
development of overt lesions postnatally. 
 
Lungs 
Lung hypoplasia is a significant cause of morbidity and mortality associated with extreme prematurity, 
particularly where preterm premature rupture (PPROM) of membranes occurs, antenatal prediction is 
therefore highly desirable for both antenatal counselling and planning subsequent neonatal care.  In addition 
when there is a period of prolonged oligohydramnios occurs, although overall survival has improved [37, 38] 
morbidity is still significant with 40% or survivors developing bronchopulmonary dysplasia[39].  
 
Ultrasound has been used to assess antenatal lung biometry as a proxy for pulmonary hypoplasia.  Methods 
included thoracic circumference[40, 41] and lung length, the latter of which proved superior and a good 
predictor of pulmonary hypoplasia predicting >90% of cases, confirmed by lung weight at postmortem[42].  
Ratios of thoracic measurements have also been generated which additionally allow for the effects of gestation 
including thoracic circumference to abdominal circumference, biparietal diameter, head circumference or 
femur length, heart area to thoracic area ratio[43-45].   
 
Ultrasound assessment of three dimensional lung volumes has been attempted, assessing right and left lungs 
separately to avoid inclusion of mediastinal structures[46].  Vergani et al demonstrated that these normograms 
were reliable for prediction of pathological pulmonary volumes[47].  Volumetric measurements have been 
found to be more reproducible when MRI is used to evaluate the tissue than 3D ultrasound[48].  MRI also 
offers better tissue contrast, a larger field of view and images are independent of fetal position.  MRI 
assessment of fetal lungs is becoming more commonplace for conditions such as congenital diaphragmatic 
hernia (CDH) and congenital cystic adenomatoid malformation (CCAM).  In these conditions MRI can 
provide volumetric assessment of normal lung tissue, important determinants of prognosis in CCAM, CDH 
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and can be used to predict pulmonary hypertension. The use of fetal lung to body volume has been shown to 
useful in the predicton of chronic lung disease in fetuses with CDH[49].  One study (n=22) reports the use of 
MRI volumetry of fetal lung assessment in cases of PPROM, finding a significant reduction in lung volume, 
particularly in cases of subsequent neonatal death[50].  
 
Infection may also be implicated in this process; some studies have shown that chorioamnionitis is associated 
with a decrease in respiratory distress syndrome but a subsequent increase in bronchopulmonary dysplasia[51, 
52], however, the data is heterogeneous and there may be confounding factors.  Further research is needed to 
investigate lung development during this critical period and MRI is well placed to do this. Automated multi-
atlas lung segmentation has been developed, generating accurate reproducible lung volumes.  Overlapping T2 
weighted stacks of the fetal thorax are obtained in the transverse plane.  Segmentations are estimated using a 
multi-atlas approach relying on 17 manually delineated lung images. Images pre and post automated 
segmentation can be seen in Figure 5.   
 
Amniotic fluid Index 
Ultrasound assessment of amniotic fluid volume is a semi-qualitiative assessment by measuring a single 
deepest vertical umbilical cord free pool or the amniotic fluid index. Although useful surrogate assessments 
they do not measure the true amniotic volume and over/under estimates can easily ensue.  Zaretsky et al 
compared MRI assessment of amniotic fluid volume with the volume collected at Caesarean section, finding 
better correlation between the MRI estimation and the actual volume at delivery than with the deepest pool 
measured on ultrasound[53]. Roberts and Mitchell found the largest amniotic pocket in serial ultrasound 
examinations on 20 patients with PPROM correlated with pulmonary hypoplasia when the maximum vertical 
pocket was less than 1.5cm[42].   A higher rate of fetal infection/inflammation associated with 
oligohydramnios has been proposed to be attributable to the antimicrobial properties of amniotic fluid[54] or 
a reduction in renal blood flow as a consequence of microbial products[55].  The AFI can be segmented from 
coronal, axial and sagittal planes using software such as ITK-SNAP to generate a 3D volume (see figure 6). 
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Fetal Thymus 
Evidence suggests that neonatal morbidity is a continuation of activation of the fetal inflammatory response 
syndrome (FIRS), a condition characterised by systemic inflammation. Diagnosis of the fetal inflammatory 
response antenatally is challenging.  Although amniocentesis can identify intra-amniotic 
infection/inflammation this is an invasive procedure.   
 
The thymus has an integral role in the development of the fetal immune system. And is the main site of T-cell 
development.  Located in the anterior mediastinum over the pericardial surface and extending into the base of 
the neck its development begins early in gestation and is completed by 20 weeks, continuing to grow in size 
until one year of age[56].  Studies in neonates have indicated a reduction in thymic size at birth (evaluated by 
measuring the cardiothymic silhouette to thoracic ratio on a chest X-ray) in very low birthweight preterm 
infants in the presence of histological chorioamniotis in the placenta[57].  A sheep model has also indicated 
that after lipopolysaccharide induced chorioamnionitis, the thymus to body weight ratios were reduced by 
40% five days later parallel to an equivalent reduction in circulating lymphocytes[58]. 
 
The fetal thymus has been assessed using ultrasound, either measuring its perimeter[59], a thymic to thoracic 
ratio[60] or using 3D ultrasound[61]. It has also been shown that measurements of thymic volume using MRI 
is feasible [62].  An MRI illustrating the fetal thymus can be seen in Figure 7.  Di Naro et al assessed 31 
women with preterm labour between 24 and 32 weeks gestation and intact membranes.  The perimeter of the 
fetal thymus was measured sonographically and an amniocentesis was performed for the assessment of 
infection of the amniotic cavity.  Placentas and umbilical cords were also examined for the presence of 
chorioamnionitis/funisitis post delivery.  16 women delivered preterm and 10 women had evidence of intra-
amniotic infection.  In all cases of intrauterine infection and in 24% of cases without intrauterine infection the 
fetal thymus perimeter was below the 5th centile for gestational age.  The fetal thymus was less than the 5th 
centile in 100%, 71.4% and 12.5% of patients with histologic signs of funisitis and isolated chorioamnionitis 
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and without histologic signs of infection respectively.  Although this study utilised ultrasound, when 
membranes are ruptured poorer views of fetal anatomical structures are obtained, consequently MRI 
assessment of thymic volume could be of significant value in establishing the FIRS and whether intra-amniotic 
infection is likely to have occurred and may help the decision making process regarding timing of delivery.  
Further studies are required to investigate this further.  
 
Prediction of the timing of delivery 
Accurately predicting when a woman is likely to deliver is important, facilitating timely hospital admission to 
ensure access to appropriate neonatal facilities whilst avoiding unnecessary and prolonged hospital stays and 
ensuring appropriate timing of antenatal therapies such as corticosteroids. It is known that the maximum 
benefit of steroids is conferred when delivery occurs between 24 hours and seven days subsequent to 
administration[63], reducing the incidence of neonatal mortality, respiratory distress syndrome, 
intraventricular haemorrhage, necrotising enterocolitis, systemic infection, the need for respiratory support 
and neonatal intensive care admission[64].  The critical timing of steroids has be highlighted by a recent mini-
commentary by Cythia Gyamfi-Bannerman[65]: although the optimum timing of steroids is known to be 
within this critical timeframe, studies have indicated that only 20% of women in threatened preterm labour 
delivered within a 24 hour to seven day period.  
 
However, antenatal steroids administration is not without risks, a recent Cochrane review indicated that 
administration of a single course of steroids resulted in a reduction of birthweight of infants born between one 
and seven days after administration compared with placebo and in those delivered more than seven days after 
the first dose.  Where repeated courses were given although a reduction in respiratory morbidity was noted, 
this was at the expense of a slight reduction in the mean birthweight[64].  Consequently it is important to 
ensure that steroids are given appropriately and enhanced prediction of which women are likely to delivery 
within a week time frame can facilitate targeted corticosteroid administration.   
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Current techniques for the prediction of PTB include biophysical and biochemical screening and a thorough 
clinical history.  Transvaginal ultrasound has been utilised in numerous research studies to assess cervical 
length and is a common clinical test used in the evaluation of women at high risk of PTB.  Although it is not 
routinely used in a low risk population, its use in such women is debated[66].  The prediction of PTB can be 
further enhanced by utilising algorithms encompassing cervical length, clinical history and quantitative fetal 
fibronectin obtained from a vaginal swab taken from the posterior fornix[67].  Although these techniques are 
extremely useful in guiding management decisions transvaginal ultrasound is often not used in cases where 
the membranes have ruptured due to the risk of introducing infection. 
 
The cervical length can be measured easily on MRI (see figure 8) but in addition, Masselli et al used diffusion 
imaging during an antenatal MRI to assess if ADC values in the maternal cervix correlated with delivery 
within a seven day period.  MRIs were performed on asymptomatic women where a sonographic measurement 
of the cervix less was than 15mm between 23 and 28 weeks gestation (n=30).  Eight women delivered within 
six days of the MRI scan and they were found to have subglandular cervical ADC values that were 
significantly higher than the women who delivered after seven days from imaging[68]. 
 
Although standard clinical practice would be to administer steroids at the time of PPROM, as the highest risk 
of delivery is within the first 24 hours, where delivery does not occur and a second course of steroids is 
considered, assessing the maternal cervix with diffusion weighted imaging at the time of a fetal MRI may 
guide decisions regarding the timing of subsequent doses of steroids in these women. 
 
Monitoring/ investigating the mechanism of action of treatment 
MRI has also been used to assess the mechanism of action of pessaries inserted around the cervix, when the 
cervical length is reduced, in an attempt to prevent further shortening and dilatation.  A randomised controlled 
trial of asymptomatic singleton pregnancies with a cervical length <25mm between 18-22 weeks found that a 
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pessary reduced delivery prior to 34 weeks by four-fold[69].  Cannie et al performed an MRI in 54 high risk 
pregnancies with a sonographic short cervix before and serially after pessary insertion and a control group of 
low risk pregnancies with no risk factors for PTB.  They reported that in singleton pregnancies at high risk of 
PTB the uterocervical angle was less acute and the cervical length shorter than in the control population.  They 
reported that failure of pessary placement occurred in 15% of patients, which was detected by MRI and 
enabled its replacement.  After successful insertion the uterocervical angle becomes more acute reducing the 
incidence of delivery prior to 34 weeks[70].  
 
Although cervical length can be monitored using ultrasound, views are often limited by pessary-induced 
shadowing.  MRI additionally facilitates the objective measurement and monitoring of the uterocervical angle.  
Although it would clearly be unfeasible to assess all pregnancies with Arabin pessaries with MRI, certain 
cases may benefit, for example where views of the cervix are poor on ultrasound or if there are concerns 
regarding correct placement. 
 
Conclusion 
We believe that assessment of pregnancies at high risk of PTB using MRI is a feasible technique and in may 
provide insight into fetal pulmonary and cerebral development, assessment of intrauterine infection, prediction 
and guidance of timing delivery and provide a means of targeting the timing of antenatal corticosteroids for 
optimal benefit. Understanding the disease processes in this cohort may also facilitate the accurate targeting 
and appropriate timing of therapeutic agents in the future given to attenuate injury to the brain and lungs and 
consequently reduce long term morbidity. 
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(a)   (b) 
Figure 1: Snapshot inversion recover T-1 weighted (a) and T2 (b) weighted MRI images of 
the fetal brain in the transverse plane in a patient at high risk of preterm birth with premature 
rupture of the membranes at 24+4 weeks gestation on a 1.5Tesla MRI scanner.  
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Figure 2: Example of a fetal spectrum, at an echo time of 136ms, illustrating the presence of 
Myo-inositol (3.5ppm), Choline (3.2ppm), Creatine (3.0ppm), N-acetylaspartate (NAA 
2.0ppm) and Lactate (inverted bifid peak at 1.3ppm) acquired at 1.5 Tesla 
 
 
  
  
Figure 3: Axial, coronal and sagittal slices of the fractional anisoptropy map of a fetal brain 
after dynamic distortion and motion correction of a x week fetus acquired on a 3T MRI 
scanner.  These results show high anisotropy in the cortex and maturing white matter structures 
such as the splenium, as expected in early brain development.  
 
Figure 4:  An apparent diffusion co-efficient map of a 24+0 fetal brain. An ADC value in a 
specific region of interest can be generated by placing a voxel in the area to be analysed. 
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(a) (b) 
Figure 5: (a) Raw T2 MRI data of fetal thorax acquired from a fetus at 31+1 weeks 
gestation. (b)  Images following automated segmentation of the fetal lungs. 
 
Figure 6: T2 weighted images obtained on a 1.5T MRI scanner showing (a) oligohydramnios 
in a 31+1 week fetus with prelabour preterm rupture of membranes (b) normal amniotic fluid 
volume in a 28+1 week fetus. 
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(a) (b) 
Figure 7: T2 weighted image illustrating the Fetal thymus at 31+6 weeks gestation in the 
coronal (a) and axial (b) planes 
 
Figure 8: T2 weighted image in the sagital plane of a 32 week fetus illustrating the maternal 
cervix 
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